Canada: Canadian Competition Bureau Releases Significant Updates To Its IP Enforcement Guidelines

On March 31, 2016, the Competition Bureau (Bureau) released revised Intellectual Property Enforcement Guidelines (IPEGs). These IPEGs reflect incremental changes to the draft version released for consultation last year. Most notably the new IPEGs provide further guidance on (i) pharmaceutical patent litigation settlements, (ii) product switching (also known as "product hopping"), (iii) collaborative standard setting and standard essential patents, and (iv) patent assertion entities.

For more information on the evolution of the IPEGs, please see our articles discussing the 2014 release for public consultation (the first update to the IPEGs since 2000) and the results of that public consultation.

Pharmaceutical Patent Litigation Settlements

The new IPEGs helpfully recognize how the unique features of Canada's regulatory system can impact settlements, and provide further clarity on the Bureau's approach to these settlements.

With respect to the 2015 draft IPEGs, we reported on how the Bureau divided settlements made in the context of Patented Medicines (Notice of Compliance) Regulations (PM(NOC)) proceedings into three categories.1 The new IPEGs provide additional guidance on the following:

  1. "Entry-split" settlements with no payment to the generic – no issue if the generic enters on or before patent expiry and there is no payment.
  2. Settlements which include a payment to the generic – possible review under sections 90.1 (civilly reviewable agreements between competitors) or 79 (abuse of dominance) of the Competition Act (Act) with the potential of an administrative monetary penalty of up to $10 million, where it is found that settlement will result in a substantial lessening of competition.
  3. Possibility of criminal review – no prospect of criminal review, unless the settlement: (a) extends beyond date of patent expiry, (b) restricts competition for products unrelated to the patent at issue in the litigation, or (c) is a "sham".

In the new IPEGs, the Bureau recognizes the unique features of the Canadian PM(NOC) system, in particular with respect to settlements which include a payment:

  • Exclusivity of first generic filer – Since there is no generic exclusivity available in law to the first generic challenger in Canada, the incentives for the first generic filer to enter into settlements may be impacted.
  • Section 8 damages– the brand firm's exposure to liability under section 8 of PM(NOC) is a relevant consideration when assessing the magnitude of any settlement payment.
  • Dual litigation – Findings in a PM(NOC) proceeding do not prevent a generic or brand firm's ability to bring subsequent patent impeachment/infringement actions. The consideration of such follow-on litigation is relevant when assessing the magnitude of settlement payment.

Product Switching

In the 2014 IPEGs, the Bureau identified product switching (also known as "product hopping") as a practice that could constitute "something more" than the mere exercise of IP rights, and could therefore be challenged under the abuse of dominance provisions. The new IPEGs create a distinction between "hard" switching and "soft" switching. Hard switching, an example of which was included in the 2014 IPEGs, occurs where a patentee removes its original product from the market for the purpose of forcing the market to switch to its new formulation product to impede generic entry. As we previously reported, the Bureau considers such conduct reviewable under the abuse of dominance provisions. Soft switching, by contrast, occurs where the patentee does not withdraw its original product from the market, but rather ceases to promote that product to physicians in favour of its new formulation product. In a new example, the Bureau states that soft switching would not raise an issue under the Act, provided that the marketing did not involve false or misleading statements about the original product.

We previously reported on a Bureau investigation into product switching here.

Collaborative Standard Setting and Standard Essential Patents

In the 2015 draft IPEGs, we reported that the Bureau recognized the value of industry standards in setting benchmarks for performance and safety and allowing for the interoperability of devices made by different manufacturers. In the new IPEGs, the Bureau maintains this view but acknowledges that competition enforcement policy in this area is in flux, and puts the public on notice that it may revisit its guidance. Even so, the Bureau made meaningful updates:

  1. Injunctions: The Bureau is concerned about the anti-competitive effects of patent hold-up (also known as "patent ambush"), where a patent holder purposely conceals its patent from a Standards Development Organization during the formation of an industry standard, and then later asserts the undisclosed patent when access to its technology is required to implement the standard. Accordingly, the Bureau may have concerns where a patentee seeks an injunction for the infringement of a standard essential patent it has committed to license on fair, reasonable and non-discriminatory (FRAND) terms. Nonetheless, the Bureau added two additional circumstances where it may conclude that such an injunction is appropriate. This is in addition to the existing grounds from the 2015 draft IPEGs, namely, where a prospective licensee has refused to pay a royalty that has been determined to be FRAND by an adjudicator, and where a prospective licensee refuses to negotiate licensing terms.
    • Where a prospective licensee constructively refuses to negotiate (e.g., refusing to consider FRAND terms).
    • Where a prospective licensee is unable to pay damages (e.g., due to bankruptcy).
  2. Enforcement Limitations: The Bureau has explicitly recognized the limitations of its enforcement activities. For example, the Bureau noted that it is not a price regulator and, as such, will not typically intervene in disputes about the quantum of a royalty rate. Similarly, in evaluating whether to take action in a patent hold-up case, the Bureau will consider whether private litigation is more appropriate.

Patent Assertion Entities

A patent assertion entity (PAE), also known as a non-practicing entity, acquires patents for the purpose of asserting them against potential infringers, without itself using the patented technologies it owns. In our post on the 2015 draft IPEGs, we reported the Bureau's statement that it could take action against PAEs under the civil or criminal misleading advertising provisions of the Act. The IPEGs include a new example in which the patentee assigns its patent to a PAE specializing in patent enforcement and enters into an arrangement to split any revenues from the enforcement of that patent. In this example, the Bureau says that while the Act may prescribe limits on to whom and how a patent may be licensed or assigned, the assignment of a patent to a PAE for the simple purpose of more effective enforcement is unlikely to raise issues under the Act.

The Bureau also states that the law with respect to PAEs is a rapidly evolving area and the Bureau may revisit its guidance in this area in the future. We report on other recent US and Canadian trends with respect to PAEs here.

* * * * *

Positively, the Bureau has provided more clarity in the new IPEGs, which gives market participants a measure of predictability as to how the Bureau will approach enforcement, thereby allowing them to plan more effectively. It is also helpful that the Bureau has picked up on major trends in the US, while still acknowledging that there are differences in Canada.


1 See also the Bureau's controversial 2014 white paper, Patent Litigation Settlement Agreements: A Canadian Perspective, that outlined its preliminary views on this topic, which we analyzed.

To view original article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions